Ravinarayan Raulo

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer.

K. Prabhash, V. Noronha, S. Laskar, 2024, European journal of cancer.